European Pharmaceutical Review

APRIL 19, 2023

This represents a compound annual growth rate (CAGR) of 15.4 Yet apart from radio-frequency identification (RFID) tags and QR codes, adoption at scale has proved challenging overall, the report stated. Types of technologies such as wirelessly connected tags (active and passive) and sensors were also specified.

Packaging 74

Packaging Labelling Compounding 74

European Pharmaceutical Review

MARCH 1, 2023

The authors explained that these are commonly used for tagging proteins for study or attaching protein drugs to drug-delivering nanoparticles. A threefold increase in the nucleation rate, how quickly the crystals grow once started, was also observed. This is a general approach that could be scaled to other systems as well.

Vaccines 93

Vaccines 93

pharmaphorum

NOVEMBER 24, 2022

One issue has been the cost of the drug, with health technology assessment agency NICE in the UK and the ICER organisation in the US both concluding its price tag means it is not a cost-effective option for health systems. and 17.6%, respectively, according to J&J’s pharma unit Janssen. and 14.1%, respectively.

Labelling 52

Labelling Hospitals 52

pharmaphorum

SEPTEMBER 15, 2020

“Digitally native brands are typically agile businesses from the ground up, and agility and flexibility are part of their core makeup,” says Joe Holmes, vice president, marketing services, US at Tag. Jeremy Richter, Tag. Joe began his life at Tag in the UK, bringing efficiencies to his clients, working across all conceivable channels.

Communication 114

Communication Documentation Labelling Vaccines 114

pharmaphorum

NOVEMBER 27, 2022

Fully integrated and automated ingredient to consumer batch tracking using barcoding, RFID tagging, or IoT temperature logging and timestamping significantly reduces the chance of these mix-ups, providing complete traceability records from ingredient manufacturer to patient, and ensures the safety of the product.

Communication 105

Communication Pharmaceutical Companies Pharmaceutical Companies Packaging 105

Pharmaceutical Technology

APRIL 5, 2023

But access to these treatments continues to remain limited due to high price tags and variable availability across regions. This approach remains logistically complex, which builds the desire for allogeneic treatments that can be manufactured from unrelated donors on a larger scale.

FDA 59

FDA Immunization 59

The Checkup by Singlecare

NOVEMBER 2, 2023

More people need treatment for obesity: The rise in obesity rates parallels the rise of GLP-1 prescriptions. The alarming increase in obesity rates heightens the need for effective weight management solutions. The high price tag is a barrier for many people. in 1999-2000 to 41.9% in 2017-2020.

Insurance 52

Insurance FDA Adverse Reactions Hospitals 52